Background Chronic obstructive pulmonary disease (COPD) is an increasingly important
cause of morbidity, disability, and mortality worldwide. We aimed to estimate global …

Disclosures: Dr. Labaki, ACP Contributing Author, reports nonfinancial support from
Pulmonx and personal fees from Konica Minolta outside the submitted work. Dr. Rosenberg …

Objective To report the global, regional, and national burden of chronic obstructive
pulmonary disease (COPD) and its attributable risk factors between 1990 and 2019, by age …

Background Although exposure to cigarette smoking and air pollution is common, the
current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the …

Background and Objectives Chronic obstructive pulmonary disease (COPD) affects over 250
million people globally, carrying a notable economic burden. This systematic literature …

Background: The presence of emphysema is relatively common in patients with fibrotic
interstitial lung disease. This has been designated combined pulmonary fibrosis and …

Background Because of the rapid change in economic development and lifestyle in China,
and the ageing population, concerns have grown that chronic obstructive pulmonary …

Persistent ill health after acute COVID-19—referred to as long COVID, the post-acute COVID-
19 syndrome, or the post-COVID-19 condition—has emerged as a major concern. We …

Пандемия новой коронавирусной инфекции (COVID19), распространяемая вирусом
SARS-CoV-2, стала вызовом системам здравоохранения всех стран мира …

Serum uric acid (SUA) is significantly elevated in obesity, gout, type 2 diabetes mellitus, and
the metabolic syndrome and appears to contribute to the renal, cardiovascular and …